B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

This targeted antibody-based strategy represents new hope for patients with aggressive, treatment-resistant cancers, including those who have previously exhausted standard immunotherapy options.

In April, the American Chemical Society Publications Division announced a new journal, ACS Nano Medicine. The peer-reviewed hybrid journal will publish research breakthroughs “in the application ...

A new immunotherapy drug could help some cancer patients avoid surgery. According to the results of a new study in the New England Journal of Medicine, 92% of patients who took this drug were ...

A new immunotherapy drug could help some cancer patients avoid surgery. According to the results of a new study in the New England Journal of Medicine, 92% of patients who took this drug were ...

Despite online rumors of a New England serial killer, law enforcement agencies say there is no evidence that the recent discoveries of several bodies are connected. Social media groups dedicated ...

The news comes weeks after a federal prosecutor in Washington sent letters to several scientific journals, including The New England Journal of Medicine, with questions that suggested that they ...

Dr. Jon LaPook reports on new clinical trial findings that suggest some cancer patients could bypass chemotherapy, radiation, and surgery thanks to promising advances in immunotherapy. Trump locks ...

radiation and surgery in favor of immunotherapy treatment, according to a new study published in the New England Journal of Medicine. NBC’s Dr. Natalie Azar joins TODAY to break down the ...